Trump Took on the International Elites at Davos. You Know They're Steaming
Dana Bash Recalibrates Both Sides of ICE Protest, and Sen. Cruz Is Guilty...
The Left Is Baby Brain Damage
Trump Blasts Canadian PM Mark Carney's Lack of Gratitude for American Strength
Tucker Carlson's Latest Newsletter Argues That a Nuclear Iran Could Be 'a Good...
Justice Clarence Thomas' Response to Hawaii Gun-Control Law, Grounded in Racist Black Code...
Trump Jokes With Newsom During His World Economic Forum Speech: 'I Would Call...
The Left's Search for a New Cause
Jury Convicts Alleged Minneapolis Gang Member in Fatal Gas Station Attack
Former TD Bank Worker Helped Launder $26 Million Through Shell Accounts, Prosecutors Say
President Trump Sounds Alarm Over UK Giving Up Key U.S. Military Base
U.S. Sues Louisiana Hospital Operator Over Alleged Medicare Fraud and Kickbacks
House Oversight Sends Contempt Resolution Against Clintons to Full House Over Epstein Prob...
Man Faces Federal Charges for Alleged Online Threats to Kill ICE Agents
The Republicans Are Launching an Investigation Into Ilhan Omar's Mysterious Net Worth Expl...
Tipsheet

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’

AP Photo/Pablo Martinez Monsivais, File

Speaking during remarks to a J.P. Morgan healthcare conference this week, Pfizer CEO Albert Bourla openly stated current vaccines the company developed for Wuhan coronavirus offer "limited, if any" protection against contracting current variants of the disease. He then encouraged booster shots. 

The statement from Bourla comes as the Biden administration continues to justify vaccine mandates for federal workers, contractors and private businesses. The Supreme Court heard arguments about President Biden's mandates for private companies and medical workers last week. A ruling is expected soon on the constitutionality of the mandates. 

A number of people who have pointed out the waning efficacy of Pfizer's vaccines, which Bourla touted last year as being "100 percent" effective against contracting or transmitting the virus, have been banned by social media companies. 

Meanwhile, Bourla also announced this week the company is developing a vaccine specific to Omicron. It is expected to be ready in March when health officials predict the latest wave of the mild variant will already be over. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos